Remedy’s third quarter revenue surged by 226% following the September 24 launch of Control Resonant, which CEO Jean-Charles Gaudechon called “a defining milestone for the company.”
Remedy’s third quarter revenue surged by 226% following the September 24 launch of Control Resonant, which CEO Jean-Charles Gaudechon called “a defining milestone for the company.”